Savant Capital LLC Cuts Stake in Cigna Group $CI

Savant Capital LLC reduced its stake in shares of Cigna Group (NYSE:CI) by 25.9% in the third quarter, Holdings Channel reports. The fund owned 11,635 shares of the health services provider’s stock after selling 4,066 shares during the quarter. Savant Capital LLC’s holdings in Cigna Group were worth $3,354,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently modified their holdings of the company. Harbor Capital Advisors Inc. grew its holdings in Cigna Group by 119.5% during the third quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock valued at $26,000 after purchasing an additional 49 shares during the period. Solstein Capital LLC bought a new position in shares of Cigna Group during the 2nd quarter worth $29,000. Chilton Capital Management LLC purchased a new stake in Cigna Group in the 2nd quarter worth about $30,000. Princeton Global Asset Management LLC raised its stake in Cigna Group by 115.6% in the 2nd quarter. Princeton Global Asset Management LLC now owns 97 shares of the health services provider’s stock valued at $32,000 after acquiring an additional 52 shares during the period. Finally, Quaker Wealth Management LLC lifted its holdings in Cigna Group by 201.0% during the second quarter. Quaker Wealth Management LLC now owns 106 shares of the health services provider’s stock valued at $35,000 after purchasing an additional 211 shares during the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Cigna Group Trading Up 2.7%

Shares of CI stock opened at $292.29 on Friday. The company has a market capitalization of $78.08 billion, a PE ratio of 13.18, a price-to-earnings-growth ratio of 1.01 and a beta of 0.27. Cigna Group has a 52-week low of $239.51 and a 52-week high of $350.00. The business’s fifty day moving average is $274.77 and its 200 day moving average is $283.95. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.76 and a current ratio of 0.74.

Cigna Group (NYSE:CI) last announced its earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, topping analysts’ consensus estimates of $7.88 by $0.20. The business had revenue of $72.50 billion for the quarter, compared to analyst estimates of $69.53 billion. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The company’s quarterly revenue was up 10.4% compared to the same quarter last year. During the same period in the prior year, the company earned $6.64 EPS. Cigna Group has set its FY 2026 guidance at 30.250- EPS. On average, equities research analysts anticipate that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, March 19th. Shareholders of record on Thursday, March 5th will be given a dividend of $1.56 per share. The ex-dividend date is Thursday, March 5th. This is a boost from Cigna Group’s previous quarterly dividend of $1.51. This represents a $6.24 annualized dividend and a yield of 2.1%. Cigna Group’s dividend payout ratio (DPR) is presently 26.64%.

Analyst Ratings Changes

Several analysts have recently issued reports on the stock. Cantor Fitzgerald lowered their price target on shares of Cigna Group from $365.00 to $325.00 in a research report on Friday, October 31st. Wolfe Research reduced their price objective on shares of Cigna Group from $345.00 to $325.00 and set an “outperform” rating for the company in a research note on Wednesday, October 15th. Barclays dropped their target price on Cigna Group from $305.00 to $303.00 and set an “overweight” rating on the stock in a research report on Friday. Mizuho set a $325.00 price target on Cigna Group in a report on Friday, January 9th. Finally, Wells Fargo & Company decreased their price objective on Cigna Group from $354.00 to $300.00 and set an “equal weight” rating on the stock in a research note on Wednesday, November 5th. One analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and five have issued a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $323.16.

Key Stories Impacting Cigna Group

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Q4 earnings and revenue beat — Cigna reported adjusted EPS of $8.08 and revenue of $72.5B, both above consensus, driven by Evernorth growth and higher specialty volumes; investors are rewarding the beat and evidence of durable revenue momentum. Cigna Q4 Highlights
• Positive Sentiment: FTC settlement over insulin pricing reduces regulatory overhang and includes commitments to change PBM pricing practices — this removes a major legal uncertainty and may support multiple expansion. FTC Settlement Coverage
• Positive Sentiment: Dividend increase — the board raised the quarterly dividend to $1.56 (3.3% increase), a modest buyback/dividend-friendly signal that supports income investors. Dividend Announcement
• Neutral Sentiment: Analyst price target moves are mixed — Leerink raised its PT to $297 but kept a “market perform” rating, while RBC trimmed its PT to $333 but maintained an “outperform” view; these moves show cautious optimism but limited near-term upside consensus. Leerink PT Change RBC PT Change
• Neutral Sentiment: Evernorth and specialty volumes are growth drivers cited on the call — supportive for revenue mix and long-term profit potential, though investors will watch margin dynamics. Evernorth Growth Coverage
• Negative Sentiment: 2026 guidance slightly below some Street expectations — Cigna set FY 2026 EPS guidance at at least $30.25, a touch under consensus and accompanied by commentary about ongoing medical-cost and margin pressure; this tempered the upside from the quarter for some investors. Guidance Miss Coverage

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.